Sign In
Last checked at 
27 Jul 2021 10:13
27 July 2021 |
|
INSPIRATION HEALTHCARE GROUP PLC
(the "Company")
Directors / PDMR Dealing
The Company has been notified that on 23 July 2021, Neil Campbell, Chief Executive of the Company and a person discharging managerial responsibility ("PDMR") in the Company, sold 35,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") at a price of 113 pence per share. At the same time, Liz Shanahan, a Non-Executive director of the Company, acquired 35,000 Ordinary Shares at a price of 114 pence per share.
Following the sale, Mr Campbell retains an interest in 4,516,646 Ordinary Shares, representing approximately 6.64 per cent. of the Company's issued ordinary share capital.
Following the purchase, Ms Shanahan has an interest in 35,000 Ordinary Shares, representing approximately 0.05 per cent. of the Company's issued ordinary share capital.
This announcement, including the notification below, is made in accordance with the requirements of the EU Market Abuse Regulation.
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a. | Name | Neil Campbell | ||||||
2 | Reason for notification |
| ||||||
a. | Position/Status | Chief Executive of Inspiration Healthcare Group plc | ||||||
b. | Initial notification/ Amendment | Initial Notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a. | Name | INSPIRATION HEALTHCARE GROUP PLC
| ||||||
b. | LEI | 213800GKFT3ENAPMDL15 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a. | Description of the financial instrument, type of instrumentIdentification Code | Ordinary Shares of 10p each
ISIN: GB00BXDZL105 | ||||||
b. | Nature of the transaction | Sale of Ordinary Shares | ||||||
c. | Price(s) and volume(s) |
|
|
|
|
| ||
| Price(s) | Volume(s) |
| |||||
113p | 35,000 |
| ||||||
| ||||||||
d. | Aggregated information - Aggregated Volume - Price
| N/A | ||||||
e. | Date of the transaction | 23 July 2021 | ||||||
f. | Place of the transaction | XLON (AIM) | ||||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a. | Name | Liz Shanahan | ||||||
2 | Reason for notification |
| ||||||
a. | Position/Status | Non-Executive Director of Inspiration Healthcare Group plc | ||||||
b. | Initial notification/ Amendment | Initial Notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a. | Name | INSPIRATION HEALTHCARE GROUP PLC
| ||||||
b. | LEI | 213800GKFT3ENAPMDL15 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a. | Description of the financial instrument, type of instrumentIdentification Code | Ordinary Shares of 10p each
ISIN: GB00BXDZL105 | ||||||
b. | Nature of the transaction | Purchase of Ordinary Shares | ||||||
c. | Price(s) and volume(s) |
|
|
|
|
| ||
| Price(s) | Volume(s) |
| |||||
114p | 35,000 |
| ||||||
| ||||||||
d. | Aggregated information - Aggregated Volume - Price
| N/A | ||||||
e. | Date of the transaction | 23 July 2021 | ||||||
f. | Place of the transaction | XLON (AIM) | ||||||
Enquiries:
Inspiration Healthcare Group plcNeil Campbell, Chief Executive OfficerJonathan Ballard, Chief Financial Officer | Tel: 01455 840 555
|
Cenkos Securities plc - Nominated Adviser & BrokerMark Connelly / Stephen Keys | Tel: 0207 397 8900
|
Cadogan PRAlex Waltersalex.walters@cadoganpr.com | Tel: 07771 713 608
|
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.
Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally, the Company has its own range of products for maintaining normothermia pre- during and post-surgery.
With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.
In the UK and Ireland, the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com
Follow the stocks
